A wearable gadget that sticks to the skin is called an electronic skin patch. It is a stick-on patch that may be worn on the body and can wirelessly collect, monitor, and send a number of health indicators, including blood pressure, blood glucose, heartbeat, temperature, and respiration, to a smartphone. Transdermal patches (drug delivery through the skin), remote monitoring (patient vitals and blood glucose), and bioelectric stimulation (chronic pain management) are the three main types of skin patches currently on the market.
Actuators, processors, sensors, and communication are all part of the electronic skin patch’s electronic capability, which enables the device to be connected to other devices.
Ultra-thin and flexible, the electronic skin patch is made for next-generation communication using sensors and microelectronics to expose information about blood oxygen levels, body temperature, and UV radiation absorption. Additionally, it is employed in therapeutic treatments and medication delivery. By minimizing hospital readmissions, decreasing prescription non-adherence, and enhancing wellness management through the use of wearables and connected smart devices to collect and analyze medical data, it can save healthcare costs.
The report “Electronic Skin Patch Market by Type (Monitoring & Diagnostic, Therapeutic), Wireless Connectivity (Connected, Non-connected), Application (Diabetes Management, Cardiovascular Monitoring, Temperature Sensing), End User and Region – Global Forecast to 2029″ The Electronic Skin Patch industry size is projected to grow from USD 15.0 billion in 2024 and is estimated to reach USD 27.0 billion by 2029; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 12.5% from 2024 to 2029. The growth of the electronic skin patch industry is driven by the rising cases of chronic diseases, growing emphasis on improving accuracy of health monitoring patches, Growing awareness about early disease detection.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167239613
The management of chronic diseases through early intervention, the encouragement of a healthy lifestyle, early diagnosis through remote monitoring, increased transparency and patient autonomy, remote monitoring and self-managed care, and the fact that the technology is disposable and affordable are just a few advantages of electronic skin patches.
There are numerous large and small manufacturers in the global market for electronic skin patches. There are currently many chances for the market’s manufacturers to grow their offerings and generate large profits. Product approvals, launches, joint ventures, agreements, partnerships, collaborations, mergers and acquisitions, and business expansions are a few of the tactics that the manufacturers employ.
Key companies operating in the Electronic Skin Patch Industry are Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia), among others.
